Skip to main content
TSE:APHA

Aphria Stock Forecast, Price & News

C$16.55
-0.98 (-5.59 %)
(As of 05/4/2021)
Add
Compare
Today's Range
C$16.41
C$17.52
50-Day Range
C$16.52
C$23.09
52-Week Range
C$3.93
C$40.93
Volume9.61 million shs
Average Volume6.16 million shs
Market CapitalizationC$5.24 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter.


Aphria logo

About Aphria

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-427-4742
Employees1,200
Year FoundedN/A

Sales & Book Value

Annual SalesC$611.06 million
Cash FlowC$0.74 per share
Book ValueC$4.76 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market CapC$5.24 billion
Next Earnings Date7/27/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.14 out of 5 stars

Analyst Opinion: 3.1Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Aphria (TSE:APHA) Frequently Asked Questions

Is Aphria a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
View analyst ratings for Aphria
or view top-rated stocks.

What stocks does MarketBeat like better than Aphria?

Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Aphria
.

How has Aphria's stock been impacted by Coronavirus?

Aphria's stock was trading at C$3.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APHA shares have increased by 349.7% and is now trading at C$16.55.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for APHA?

6 Wall Street analysts have issued 12-month price objectives for Aphria's shares. Their forecasts range from C$10.75 to C$28.00. On average, they expect Aphria's stock price to reach C$18.34 in the next year. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for Aphria
or view top-rated stocks among Wall Street analysts.

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Mr. Irwin D. Simon, CEO & Chairman (Age 62, Pay $6.54M)
  • Mr. Carl A. Merton, Chief Financial Officer
  • Dr. Christelle Gedeon L.L.B., Ph.D., Chief Legal Officer & Corp. Sec.
  • Mr. James R. Meiers, Chief Operating Officer of Aphria Leamington
  • Ms. Denise Menikheim Faltischek, Chief Strategy Officer & MD of Aphria Germany (Age 48, Pay $562.35k)
  • Mr. John B. Sadler, VP of Investor Relations
  • Mr. Bernard Yeung, Sr. VP of Sales & Marketing
  • Mr. Victor Neufeld, Special Advisor (Age 67)
  • Mr. Cole Cacciavillani, Special Advisor (Age 66)
  • Mr. Randy Daigneau, Sr. VP of Supply Chain

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), KushCo (KSHB), NVIDIA (NVDA), CannTrust (CTST), Cronos Group (CRON) and Cronos Group (CRON).

What is Aphria's stock symbol?

Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."

How do I buy shares of Aphria?

Shares of APHA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately C$16.55.

How much money does Aphria make?

Aphria has a market capitalization of C$5.24 billion and generates C$611.06 million in revenue each year.

How many employees does Aphria have?

Aphria employs 1,200 workers across the globe.

What is Aphria's official website?

The official website for Aphria is www.aphria.com.

Where are Aphria's headquarters?

Aphria is headquartered at 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada.

How can I contact Aphria?

Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742.


This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.